87.45
price up icon1.66%   1.43
after-market Dopo l'orario di chiusura: 87.45
loading
Precedente Chiudi:
$86.02
Aprire:
$86.29
Volume 24 ore:
352.13K
Relative Volume:
0.34
Capitalizzazione di mercato:
$4.41B
Reddito:
-
Utile/perdita netta:
$-38.99M
Rapporto P/E:
-29.18
EPS:
-2.9966
Flusso di cassa netto:
$-24.94M
1 W Prestazione:
+2.26%
1M Prestazione:
+7.41%
6M Prestazione:
+81.09%
1 anno Prestazione:
+80.68%
Intervallo 1D:
Value
$86.22
$87.58
Intervallo di 1 settimana:
Value
$84.73
$88.86
Portata 52W:
Value
$41.50
$90.32

Soleno Therapeutics Inc Stock (SLNO) Company Profile

Name
Nome
Soleno Therapeutics Inc
Name
Telefono
650-213-8444
Name
Indirizzo
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Name
Dipendente
92
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-05
Name
Ultimi documenti SEC
Name
SLNO's Discussions on Twitter

Confronta SLNO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SLNO
Soleno Therapeutics Inc
87.45 4.54B 0 -38.99M -24.94M -2.9966
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-23 Iniziato TD Cowen Buy
2025-03-05 Ripresa Stifel Buy
2024-12-02 Reiterato Robert W. Baird Outperform
2024-12-02 Reiterato Stifel Buy
2024-09-03 Iniziato H.C. Wainwright Buy
2024-05-10 Iniziato Robert W. Baird Outperform
2024-02-05 Iniziato Piper Sandler Overweight
2024-01-23 Iniziato Stifel Buy
2023-11-21 Ripresa Guggenheim Buy
2020-09-29 Iniziato Guggenheim Buy
2020-01-10 Iniziato Craig Hallum Buy
2019-12-23 Iniziato Oppenheimer Outperform
2018-02-13 Reiterato Maxim Group Buy
Mostra tutto

Soleno Therapeutics Inc Borsa (SLNO) Ultime notizie

pulisher
Jul 23, 2025

What analysts say about Soleno Therapeutics Inc. stockFree Risk Assessment Services - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Can Soleno Therapeutics (SLNO) Climb 33.11% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

Here's What Could Help Soleno Therapeutics (SLNO) Maintain Its Recent Price Strength - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

Soleno Therapeutics Inc. Stock Analysis and ForecastFree Consultation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Soleno’s Rare Disease Drug Launch Turns Heads On Wall Street - Finimize

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Soleno Therapeutics Inc. stock priceExplosive earning power - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Soleno Therapeutics Inc. a good long term investmentConsistently high yield - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Soleno Therapeutics’ Vykat XR Exceeds Sales Expectations - MSN

Jul 21, 2025
pulisher
Jul 19, 2025

Soleno gains as Betaville cites buyout interest (update) - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

(SLNO) Trading Report - news.stocktradersdaily.com

Jul 18, 2025
pulisher
Jul 16, 2025

Soleno Therapeutics: A Strategic Capital Raise Balances M&A Optionality with Long-Term Growth Potential - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Soleno Therapeutics: Fairly Valued Despite M&A Expectations - Seeking Alpha

Jul 16, 2025
pulisher
Jul 15, 2025

Soleno Therapeutics (SLNO) Receives a Buy from Oppenheimer - The Globe and Mail

Jul 15, 2025
pulisher
Jul 14, 2025

Mintz Advises on Soleno Therapeutics’ $200 Million Public Offering - Mintz

Jul 14, 2025
pulisher
Jul 13, 2025

Soleno Therapeutics Shares Dip Following $200 Million Stock Offering Pricing - MSN

Jul 13, 2025
pulisher
Jul 12, 2025

Soleno Therapeutics stock dips on proposed $200M offering - MSN

Jul 12, 2025
pulisher
Jul 12, 2025

Baird Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Raises Target Price to $121 - 富途牛牛

Jul 12, 2025
pulisher
Jul 11, 2025

Stifel reiterates Buy rating on Soleno Therapeutics stock amid strong Vykat launch - Investing.com Nigeria

Jul 11, 2025
pulisher
Jul 11, 2025

Stifel reiterates Buy rating on Soleno Therapeutics stock amid strong Vykat launch By Investing.com - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 11, 2025

Soleno Therapeutics Announces Public Stock Offering - TipRanks

Jul 11, 2025
pulisher
Jul 11, 2025

In Brief: Soleno To Raise $200m To Boost Vykat XR Launch - insights.citeline.com

Jul 11, 2025
pulisher
Jul 11, 2025

Soleno Therapeutics stock soars as Stifel reiterates Buy on strong Vykat sales - Investing.com Australia

Jul 11, 2025
pulisher
Jul 11, 2025

Soleno Therapeutics prices $200M public offering - MSN

Jul 11, 2025
pulisher
Jul 11, 2025

Baird raises Soleno Therapeutics stock price target to $121 on strong Vykat XR sales By Investing.com - Investing.com South Africa

Jul 11, 2025
pulisher
Jul 11, 2025

Soleno Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock - GlobeNewswire

Jul 11, 2025
pulisher
Jul 10, 2025

Baird raises Soleno Therapeutics stock price target to $121 on strong Vykat XR sales - Investing.com Nigeria

Jul 10, 2025
pulisher
Jul 10, 2025

Firm Advises Soleno Therapeutics on $200 Million Public Offering - Wilson Sonsini

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno reports preliminary Q2 revenue of $31-33 million for VYKAT XR - Investing.com Nigeria

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics Announces Proposed $200 Million Public Offering of Common Stock - GlobeNewswire

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno sales of new Prader-Willi drug rise faster than expected - BioPharma Dive

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics Prices $200 Mln Public Offering To Support VYKAT XR Launch - Nasdaq

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics stock falls after pricing $200 million offering By Investing.com - Investing.com Canada

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics stock falls after pricing $200 million offering - Investing.com

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics prices public offering at $85 per share - Investing.com

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics prices public offering at $85 per share By Investing.com - Investing.com South Africa

Jul 10, 2025
pulisher
Jul 10, 2025

Soleno Therapeutics Secures $200M Public Offering to Commercialize Breakthrough Prader-Willi Treatment - Stock Titan

Jul 10, 2025

Soleno Therapeutics Inc Azioni (SLNO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):